Logo image of ASXC

Asensus Surgical Inc (ASXC) Stock Analyst Earnings Estimates

NYSEARCA:ASXC - NYSE Arca - US04367G1031 - Common Stock - Currency: USD

0.3479  +0 (+0.64%)

After market: 0.3487 +0 (+0.23%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ASXC revenue by date.ASXC revenue by date.
8.23M
158.81%
7.09M
-13.85%
8.577M
20.97%
12.302M
43.43%
22.35M
81.68%
52.409M
134.49%
108.6M
107.22%
158.4M
45.86%
218.77M
38.11%
304.36M
39.12%
EBITDA
YoY % growth
ASXC ebitda by date.ASXC ebitda by date.
-50.51M
-10.19%
-63.17M
-25.06%
-75.365M
-19.31%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ASXC ebit by date.ASXC ebit by date.
-64.62M
-8.53%
-74.25M
-14.90%
-79.094M
-6.52%
-67.593M
14.54%
-56.414M
16.54%
-26.688M
52.69%
9.891M
137.06%
46.395M
369.06%
84.111M
81.29%
135.44M
61.03%
Operating Margin
ASXC operating margin by date.ASXC operating margin by date.
-785.18%-1,047.25%-922.16%-549.45%-252.41%-50.92%9.11%29.29%38.45%44.50%
EPS
YoY % growth
ASXC eps by date.ASXC eps by date.
-0.24
71.08%
-0.32
-33.33%
-0.31
3.13%
-0.24
21.03%
-0.19
20.83%
-0.08
57.89%
0.03
137.50%
0.12
300.00%
0.22
83.33%
0.36
59.09%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.06
19.86%
-0.04
32.00%
-0.03
61.75%
-0.03
66.00%
-0.03
45.45%
-0.03
25.00%
Revenue
Q2Q % growth
3.619M
232.32%
6.292M
15.85%
7.752M
590.29%
7.956M
260.49%
7.956M
119.84%
8.466M
34.55%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-15.452M
23.73%
-13.572M
13.13%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
-0.09 -0.06-0.03-47.06%
Q1 2024
Q2Q % growth
-0.08
11.11%
-0.05-0.03-56.86%
Q4 2023
Q2Q % growth
-0.06
25.00%
-0.080.0226.47%
Q3 2023
Q2Q % growth
-0.07
12.50%
-0.070.001.96%
Q2 2023
Q2Q % growth
-0.09
-12.50%
-0.08-0.01-10.29%
Q1 2023
Q2Q % growth
-0.09
-12.50%
-0.08-0.01-10.29%
Q4 2022
Q2Q % growth
-0.08
-14.29%
-0.080.001.96%
Q3 2022
Q2Q % growth
-0.08
-33.33%
-0.07-0.01-12.04%
Q2 2022
Q2Q % growth
-0.08
-60.00%
-0.080.001.96%
Q1 2022
Q2Q % growth
-0.08
-33.33%
-0.080.001.96%
Q4 2021
Q2Q % growth
-0.07
22.22%
-0.070.001.96%
Q3 2021
Q2Q % growth
-0.06
50.00%
-0.060.001.96%
Q2 2021
Q2Q % growth
-0.05
76.19%
-0.060.0118.30%
Q1 2021
Q2Q % growth
-0.06
85.37%
-0.070.0115.97%
Q4 2020
Q2Q % growth
-0.09
89.16%
-0.110.0219.79%
Q3 2020
Q2Q % growth
-0.12
89.74%
-0.230.1148.85%
Q2 2020
Q2Q % growth
-0.21
82.05%
-0.390.1845.82%
Q1 2020
Q2Q % growth
-0.41
64.96%
-0.540.1324.16%
Q4 2019
Q2Q % growth
-0.83 -0.63-0.20-31.25%
Q3 2019
Q2Q % growth
-1.17 -1.03-0.14-13.12%
Q2 2019
Q2Q % growth
-1.17 -1.06-0.11-10.29%
Q1 2019
Q2Q % growth
-1.17 -1.09-0.08-7.60%
ASXC Yearly EPS VS EstimatesASXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6 -8 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
2.207M
104.16%
1.256M951K75.72%
Q1 2024
Q2Q % growth
1.123M
15.06%
1.221M-98K-8.03%
Q4 2023
Q2Q % growth
5.431M
120.77%
5.406M25K0.46%
Q3 2023
Q2Q % growth
1.089M
-57.46%
2.027M-938K-46.28%
Q2 2023
Q2Q % growth
1.081M
9.19%
1.092M-11K-1.01%
Q1 2023
Q2Q % growth
976K
-8.79%
2.04M-1.064M-52.16%
Q4 2022
Q2Q % growth
2.46M
-0.81%
2.55M-90K-3.53%
Q3 2022
Q2Q % growth
2.56M
-0.39%
2.958M-398K-13.46%
Q2 2022
Q2Q % growth
990K
-10.00%
1.274M-284K-22.29%
Q1 2022
Q2Q % growth
1.07M
-48.56%
1.326M-256K-19.31%
Q4 2021
Q2Q % growth
2.48M
123.42%
1.537M943K61.35%
Q3 2021
Q2Q % growth
2.57M
217.28%
1.039M1.531M147.35%
Q2 2021
Q2Q % growth
1.1M
66.67%
1.53M-430K-28.10%
Q1 2021
Q2Q % growth
2.08M
246.67%
1.427M653K45.76%
Q4 2020
Q2Q % growth
1.11M
60.87%
1.077M33K3.06%
Q3 2020
Q2Q % growth
810K
-59.90%
786.93K23.07K2.93%
Q2 2020
Q2Q % growth
660K
-81.87%
427.38K232.62K54.43%
Q1 2020
Q2Q % growth
600K
-72.48%
1.305M-705K-54.02%
Q4 2019
Q2Q % growth
690K 3.983M-3.293M-82.68%
Q3 2019
Q2Q % growth
2.02M 4.96M-2.94M-59.27%
Q2 2019
Q2Q % growth
3.64M 5.129M-1.489M-29.03%
Q1 2019
Q2Q % growth
2.18M 5.931M-3.751M-63.24%
ASXC Yearly Revenue VS EstimatesASXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -20% 0% -29.73%
Revenue0% -3.9% 0% -1.91%